Complications of collagen biostimulators in Brazil: Description of products, treatments, and evolution of 55 cases
Journal of Cosmetic Dermatology · 2024-09 · 23 (9) · 2829-2835
DOI: 10.1111/jocd.16343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 01.05.2024. Verfasst von Mayra Ianhez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Goiás, Goiânia, Brazil. Hauptthemen laut MEDLINE: Durapatite, Polyesters, Dermal Fillers. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Complications of temporary and permanent fillers have been extensively studied. However, there is a lack of comparative data regarding poly‐L‐lactic acid (PLLA), calcium hydroxyapatite (CaHA), and polycaprolactone (PCL) known as collagen biostimulators.
Aims
This study addressed the complications of collagen biostimulators concerning their diagnosis, type of product, treatment, and monitoring. Patients/Methods An electronic questionnaire was sent to Brazilian dermatologic ultrasound experts to identify complications related to biostimulators. The type of biostimulator, location of application, number of vials injected, application plan, time between injection treatment and complication, injector profile, treatment, and prognosis were assessed.
Results
Fifty‐five cases were identified, of which 49.1% were caused by PLLA‐Elleva®, 23.6% by CaHA (alone or combined with hyaluronic acid), 20.0% by PLLA‐Sculptra®, and 7.3% by PCL. The most affected area was the face (72.7%), with nodules being the most common clinical form (89.1%), generally occurring late (60.0%) (>1 month). Only one case was injected at an incorrect depth (musculoaponeurotic system—SMAS). Despite several treatments, including saline (45.5%), hyaluronidase (25.5%), diluted corticosteroids (23.6%), and energy‐based devices (10.9%), only five cases showed complete resolution. Hyaluronidase was beneficial in complications related to fillers when there was an association of calcium hydroxyapatite with hyaluronic acid ( p < 0.01).
Conclusions
Complications from collagen biostimulators were more common on the face, typically manifesting about 1 month after treatment. These issues seemed to be related more to the properties of the products rather than inadequate technique. Furthermore, hyaluronidase demonstrated efficacy only in cases where there was an association with HA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Federal de Goiás, Goiânia, Brazil.
- Instituto de Radiologia da Faculdade de Medicina da USP, São Paulo, Brazil.
- Pontifícia Universidade de Campinas, Campinas, Brazil.
- Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil.
- Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, Brazil.
ORCID-Profile: Mayra Ianhez, Giselle de Goés E Silva Freire, Rosa Maria Silveira Sigrist, Paula Tavares Colpas, Isabella Alves de Faria, Meire Odete Américo Brasil Parada, Hélio Amante Miot
Zitieren
APA
Ianhez, M., de Goés E Silva Freire, G., Sigrist, R. M. S., Colpas, P. T., de Faria, I. A., Parada, M. O. A. B., & Miot, H. A. (2024). Complications of collagen biostimulators in Brazil: Description of products, treatments, and evolution of 55 cases. Journal of Cosmetic Dermatology, 23(9), 2829-2835. https://doi.org/10.1111/jocd.16343
Vancouver
Ianhez M, de Goés E Silva Freire G, Sigrist RMS, Colpas PT, de Faria IA, Parada MOAB, et al. Complications of collagen biostimulators in Brazil: Description of products, treatments, and evolution of 55 cases. Journal of Cosmetic Dermatology. 2024;23(9):2829-2835. doi:10.1111/jocd.16343
BibTeX
@article{Ianhez2024,
author = {Ianhez, Mayra and de Goés E Silva Freire, Giselle and Sigrist, Rosa Maria Silveira and Colpas, Paula Tavares and de Faria, Isabella Alves and Parada, Meire Odete Américo Brasil and Miot, Hélio Amante},
title = {Complications of collagen biostimulators in Brazil: Description of products, treatments, and evolution of 55 cases},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
volume = {23},
number = {9},
pages = {2829--2835},
doi = {10.1111/jocd.16343}
}
EUVIMED